Waters Income from Continuous Operations 2010-2025 | WAT
Waters annual/quarterly income from continuous operations history and growth rate from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- Waters income from continuous operations for the quarter ending June 30, 2025 was $0.147B, a 3.06% increase year-over-year.
- Waters income from continuous operations for the twelve months ending June 30, 2025 was $0.661B, a 11.03% increase year-over-year.
- Waters annual income from continuous operations for 2024 was $0.638B, a 0.69% decline from 2023.
- Waters annual income from continuous operations for 2023 was $0.642B, a 9.26% decline from 2022.
- Waters annual income from continuous operations for 2022 was $0.708B, a 2.15% increase from 2021.
| Waters Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $638 |
| 2023 | $642 |
| 2022 | $708 |
| 2021 | $693 |
| 2020 | $522 |
| 2019 | $592 |
| 2018 | $594 |
| 2017 | $20 |
| 2016 | $522 |
| 2015 | $469 |
| 2014 | $432 |
| 2013 | $450 |
| 2012 | $461 |
| 2011 | $433 |
| 2010 | $382 |
| 2009 | $323 |
| Waters Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-06-30 | $147 |
| 2025-03-31 | $121 |
| 2024-12-31 | $231 |
| 2024-09-30 | $162 |
| 2024-06-30 | $143 |
| 2024-03-31 | $102 |
| 2023-12-31 | $216 |
| 2023-09-30 | $135 |
| 2023-06-30 | $151 |
| 2023-03-31 | $141 |
| 2022-12-31 | $227 |
| 2022-09-30 | $156 |
| 2022-06-30 | $165 |
| 2022-03-31 | $160 |
| 2021-12-31 | $216 |
| 2021-09-30 | $161 |
| 2021-06-30 | $167 |
| 2021-03-31 | $148 |
| 2020-12-31 | $218 |
| 2020-09-30 | $127 |
| 2020-06-30 | $123 |
| 2020-03-31 | $54 |
| 2019-12-31 | $201 |
| 2019-09-30 | $138 |
| 2019-06-30 | $144 |
| 2019-03-31 | $109 |
| 2018-12-31 | $185 |
| 2018-09-30 | $141 |
| 2018-06-30 | $156 |
| 2018-03-31 | $112 |
| 2017-12-31 | $-353 |
| 2017-09-30 | $136 |
| 2017-06-30 | $132 |
| 2017-03-31 | $106 |
| 2016-12-31 | $174 |
| 2016-09-30 | $125 |
| 2016-06-30 | $128 |
| 2016-03-31 | $94 |
| 2015-12-31 | $151 |
| 2015-09-30 | $116 |
| 2015-06-30 | $106 |
| 2015-03-31 | $96 |
| 2014-12-31 | $151 |
| 2014-09-30 | $113 |
| 2014-06-30 | $97 |
| 2014-03-31 | $70 |
| 2013-12-31 | $142 |
| 2013-09-30 | $98 |
| 2013-06-30 | $89 |
| 2013-03-31 | $121 |
| 2012-12-31 | $176 |
| 2012-09-30 | $99 |
| 2012-06-30 | $98 |
| 2012-03-31 | $89 |
| 2011-12-31 | $137 |
| 2011-09-30 | $101 |
| 2011-06-30 | $100 |
| 2011-03-31 | $94 |
| 2010-12-31 | $127 |
| 2010-09-30 | $95 |
| 2010-06-30 | $85 |
| 2010-03-31 | $76 |
| 2009-12-31 | $104 |
| 2009-09-30 | $76 |
| 2009-06-30 | $70 |
| 2009-03-31 | $73 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $17.663B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.846B | 22.60 |
| Intuitive Surgical (ISRG) | United States | $172.230B | 71.39 |
| IDEXX Laboratories (IDXX) | United States | $51.191B | 53.28 |
| Edwards Lifesciences (EW) | United States | $47.784B | 31.67 |
| Alcon (ALC) | Switzerland | $39.973B | 26.83 |
| IQVIA Holdings (IQV) | United States | $32.647B | 18.45 |
| DexCom (DXCM) | United States | $32.027B | 48.04 |
| Mettler-Toledo (MTD) | United States | $27.126B | 32.20 |
| STERIS (STE) | Ireland | $24.578B | 26.16 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.277B | 0.00 |
| Hologic (HOLX) | United States | $15.294B | 16.57 |
| Penumbra (PEN) | United States | $9.973B | 72.86 |
| Sysmex ADR (SSMXY) | Japan | $8.372B | 26.60 |
| Globus Medical (GMED) | United States | $8.202B | 18.92 |
| Masimo (MASI) | United States | $7.912B | 26.63 |
| Teleflex (TFX) | United States | $5.553B | 8.96 |
| Glaukos (GKOS) | United States | $5.215B | 0.00 |
| TransMedics (TMDX) | United States | $4.155B | 63.15 |
| Integer Holdings (ITGR) | United States | $3.759B | 18.76 |
| LivaNova (LIVN) | United Kingdom | $2.915B | 16.68 |
| Veracyte (VCYT) | United States | $2.320B | 32.05 |
| PROCEPT BioRobotics (PRCT) | United States | $2.191B | 0.00 |
| Artivion (AORT) | United States | $2.030B | 102.43 |
| Nihon Kohden (NHNKY) | Japan | $1.894B | 22.61 |
| Elekta AB (EKTAY) | Sweden | $1.854B | 17.34 |
| Integra LifeSciences Holdings (IART) | United States | $1.111B | 6.37 |
| OPKO Health (OPK) | United States | $1.103B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.073B | 0.00 |
| IRadimed (IRMD) | United States | $0.888B | 43.10 |
| Tandem Diabetes Care (TNDM) | United States | $0.722B | 0.00 |
| SiBone (SIBN) | United States | $0.670B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.574B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.462B | 3.71 |
| Treace Medical Concepts (TMCI) | United States | $0.451B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.381B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.379B | 9.63 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.361B | 86.08 |
| RxSight (RXST) | United States | $0.346B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.286B | 19.72 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.234B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.223B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| Inogen (INGN) | United States | $0.199B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.148B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.112B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.109B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.073B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 23.33 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.027B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.023B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Vyome Holdings (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.33 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |